Evaluation of antimicrobial agents in the treatment of septicemia (lecture).
D000617:Aminoglycosides / Q000627:therapeutic use; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002228:Carbenicillin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D003023:Cloxacillin / Q000627:therapeutic use; D004009:Dicloxacillin / Q000627:therapeutic use; D006801:Humans; D008712:Methicillin / Q000627:therapeutic use; D009254:Nafcillin / Q000627:therapeutic use; D010068:Oxacillin / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D010403:Penicillin Resistance; D018805:Sepsis / Q000188:drug therapy*; D013754:Tetracyclines / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D013754:Tetracyclines; D002981:Clindamycin; D009254:Nafcillin; D002701:Chloramphenicol; D000667:Ampicillin; D004009:Dicloxacillin; D002228:Carbenicillin; D003023:Cloxacillin; D010400:Penicillin G; D008712:Methicillin; D010068:Oxacillin